Free standard shipping on orders $300+ · Same-day dispatch before 2PM AEST
AUSTRALIAN OWNED & OPERATED
FAST DISCREET SHIPPING AUSTRALIA WIDE
LAB TESTED FOR PURITY & QUALITY
Customer Support:
contact@aussiepeptideco.com
Batch-verified · ≥99.0% purity (HPLC) Batch ZL-33-30 · Tested by Janoshik Analytical · 11/06/2026
View COA
Metabolic Research

Tirzepatide 30mg

Dual GIP / GLP-1 receptor agonist

Be the first to review SKU: APC-TIRZEPATIDE-30MG
Purity
≥99.0%
Lab Tested
Third-Party
Batch Specific
COA
$259.99 AUD
In Stock

Also available in 10mg · 15mg · 45mg · 60mg — compare all sizes

Quantity
Order within for same-day dispatch
Secure CheckoutSSL Encrypted
Fast Australia WideDiscreet Shipping
Orders before 2pm AESTDispatched Same Day

Also searched as: Tirz, GIP/GLP-1 dual agonist

Trusted Zynova Labs Supplier Genuine Zynova Labs research vials, stocked and dispatched from Melbourne.

Third-Party Tested

HPLC & mass spec verified purity

Batch Specific COA

Certificate with every batch

Discreet Packaging

Plain, unbranded, tamper-evident

Same-Day Dispatch

Before 2PM AEST, Australia-wide

Tirzepatide 30mg is a research compound supplied for laboratory and scientific investigation. Tirzepatide is a synthetic peptide designed to interact with both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual-receptor activity has made Tirzepatide 30mg relevant to experimental studies examining metabolic signalling, glucose regulation and energy-balance pathways.

What Is Tirzepatide 30mg?

Tirzepatide is a long-acting peptide that acts as an agonist at GIP and GLP-1 receptors. These receptors participate in several interconnected metabolic and endocrine signalling pathways.

Unlike compounds that primarily target GLP-1 receptors alone, tirzepatide provides researchers with a model for investigating simultaneous activation of two incretin-related receptor systems. The 30mg format provides a defined quantity for controlled laboratory research and analytical applications.

ManufacturerZynova Labs
Strength30mg
Molecular FormulaC225H348N48O68
Molecular Weight4813.5 g/mol
Purity≥99.0% (HPLC, batch ZL-33-30)
AppearanceWhite lyophilised powder
CAS No.2023788-19-2
FormLyophilised Powder
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryMetabolic Research
UsageFor Research Use Only. Not for human consumption.

Key Research Areas

Tirzepatide has been investigated across several areas of metabolic science. Research has examined its relationship with GIP and GLP-1 receptor signalling, glucose-dependent pathways, insulin-related signalling and mechanisms associated with energy balance.

Its dual-agonist design is also of interest when comparing single-receptor and multi-receptor approaches in experimental metabolic models. Findings should be interpreted according to the specific study design and should not be assumed to represent outcomes outside controlled research settings.

Why Researchers Study Tirzepatide

A central feature of tirzepatide is its ability to engage two distinct but related receptor pathways. GIP and GLP-1 are incretin hormones involved in physiological responses associated with nutrient intake and metabolic regulation.

Studying these pathways together can help researchers investigate how combined receptor activation influences downstream cellular and endocrine signalling. This mechanism distinguishes tirzepatide from GLP-1-selective research compounds.

Tirzepatide 30mg in Australia

Researchers searching for Tirzepatide 30mg Australia should review the product specification, current stock information, analytical documentation and shipping details before ordering. Product-specific information should clearly distinguish the nominal 30mg specification from any analytical measurement reported on the relevant CoA.

This product is intended strictly for laboratory and in-vitro research purposes. It has not been evaluated for human or veterinary use, and any information provided here is for educational reference only.

Specifications

Product NameTirzepatide 30mg
ManufacturerZynova Labs
Strength30mg
Molecular FormulaC225H348N48O68
Molecular Weight4813.5 g/mol
Purity≥99.0% (HPLC, batch ZL-33-30)
AppearanceWhite lyophilised powder
CAS No.2023788-19-2
FormLyophilised Powder
VialSealed, sterile glass vial
StorageStore at -20°C, protect from light & moisture
SolubilitySoluble in bacteriostatic water
Research CategoryMetabolic Research
TestingIndependent third-party HPLC & MS
DocumentationBatch-specific COA included
UsageFor Research Use Only. Not for human consumption.

Certificate of Analysis

Quality and Batch Testing

Researchers should verify the analytical specifications of Tirzepatide 30mg using the batch documentation supplied with the product. Where available, a batch-specific Certificate of Analysis (CoA) can provide information concerning analytical identity, purity and testing methodology.

Analytical purity should not be interpreted as evidence of clinical safety, suitability or therapeutic effectiveness.

CERTIFICATE OF ANALYSIS
Tirzepatide 30mg
Batch: ZL-33-30 · 11/06/2026
Janoshik Analytical Certificate of Analysis for Tirzepatide 30mg

Storage & Handling

Storage and Laboratory Handling

Tirzepatide should be stored and handled according to the verified conditions stated in its batch documentation. Researchers should avoid assuming post-reconstitution stability periods, solvents or storage temperatures unless these have been specifically validated for the supplied material.

Unopened VialStore at -20°C, protect from light & moisture
ReconstitutionBacteriostatic water (recommended)
After ReconstitutionRefrigerate at 2–8°C, use within 4 weeks
HandlingUse appropriate PPE and standard laboratory safety procedures
ShippingTracked, discreet delivery Australia-wide via Australia Post. Express available.

Reconstitution calculator: Tirzepatide 30mg

Work out concentration and the volume to draw for each aliquot before you add diluent.

mg
mL
Concentration
–
Volume per aliquot
–
On a 1 mL (U-100) syringe
–
Aliquots per vial
–

A laboratory arithmetic aid only. Verify every calculation independently. Not dosing guidance; research use only.

For Research Use Only. Not for human or veterinary consumption.

Tirzepatide 30mg: Frequently Asked Questions

No. This product is supplied strictly for in-vitro laboratory research. It is not approved for human or veterinary use and must not be consumed or administered.

Orders placed before 2PM AEST on business days are dispatched the same day from Melbourne. Standard Post takes 3–7 business days and Express Post 1–3 business days, both tracked and discreet.

Reviews

There are no reviews yet.

Be the first to review “Tirzepatide 30mg”

Your email address will not be published. Required fields are marked *

Shopping Cart (0 items)

Your cart is empty

Add some research compounds to get started.

Browse Products